HRP931445B1 - Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions - Google Patents

Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions

Info

Publication number
HRP931445B1
HRP931445B1 HRP-925/91A HRP931445A HRP931445B1 HR P931445 B1 HRP931445 B1 HR P931445B1 HR P931445 A HRP931445 A HR P931445A HR P931445 B1 HRP931445 B1 HR P931445B1
Authority
HR
Croatia
Prior art keywords
glutaminate
pyridoxal
phosphate
magnesium
diseases
Prior art date
Application number
HRP-925/91A
Other languages
English (en)
Inventor
Werner Schneider
Britta Meyer
F Erich Elstner
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of HRP931445A2 publication Critical patent/HRP931445A2/xx
Publication of HRP931445B1 publication Critical patent/HRP931445B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP-925/91A 1990-05-25 1993-11-26 Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions HRP931445B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (de) 1990-05-25 1990-05-25 Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben
YU92591 1991-05-23

Publications (2)

Publication Number Publication Date
HRP931445A2 HRP931445A2 (en) 1996-02-29
HRP931445B1 true HRP931445B1 (en) 2000-04-30

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-925/91A HRP931445B1 (en) 1990-05-25 1993-11-26 Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions

Country Status (28)

Country Link
US (1) US5372999A (uk)
EP (1) EP0458287B1 (uk)
JP (1) JPH07119174B2 (uk)
KR (1) KR970005180B1 (uk)
CN (1) CN1050750C (uk)
AT (1) ATE142884T1 (uk)
AU (1) AU651108B2 (uk)
CA (1) CA2043228C (uk)
CZ (1) CZ280683B6 (uk)
DE (2) DE4016963A1 (uk)
DK (1) DK0458287T3 (uk)
EG (1) EG19730A (uk)
ES (1) ES2091262T3 (uk)
GR (1) GR3021077T3 (uk)
HR (1) HRP931445B1 (uk)
HU (1) HU219223B (uk)
IE (1) IE76728B1 (uk)
IL (1) IL98156A (uk)
IN (1) IN173057B (uk)
LT (1) LT3335B (uk)
LV (1) LV10046B (uk)
MD (1) MD306C2 (uk)
MX (1) MX171883B (uk)
RU (1) RU2041713C1 (uk)
SI (1) SI9110925A (uk)
SK (1) SK278896B6 (uk)
UA (1) UA26973A1 (uk)
ZA (1) ZA913692B (uk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (de) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
WO2001003682A2 (en) * 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
EP1872797A3 (en) * 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
DE60110054T2 (de) 2000-02-29 2006-03-09 Medicure International Inc. Cardioprotektive phosphonate
EP1278526A2 (en) 2000-03-28 2003-01-29 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2680801A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule
RU2484843C1 (ru) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (uk)
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker

Also Published As

Publication number Publication date
KR970005180B1 (ko) 1997-04-14
LV10046A (lv) 1994-05-10
HRP931445A2 (en) 1996-02-29
LT3335B (en) 1995-07-25
US5372999A (en) 1994-12-13
KR910019616A (ko) 1991-12-19
HUT58204A (en) 1992-02-28
CZ280683B6 (cs) 1996-04-17
MX171883B (es) 1993-11-22
SI9110925A (sl) 1998-06-30
ZA913692B (en) 1992-02-26
AU651108B2 (en) 1994-07-14
IL98156A (en) 1996-06-18
IL98156A0 (en) 1992-06-21
EP0458287B1 (en) 1996-09-18
AU7730191A (en) 1991-11-28
MD306C2 (ro) 1996-02-29
DE69122170D1 (de) 1996-10-24
CN1050750C (zh) 2000-03-29
GR3021077T3 (en) 1996-12-31
IN173057B (uk) 1994-02-05
DE69122170T2 (de) 1997-02-20
EP0458287A2 (en) 1991-11-27
RU2041713C1 (ru) 1995-08-20
SK278896B6 (sk) 1998-04-08
JPH04235130A (ja) 1992-08-24
MD306B1 (ro) 1995-10-31
CS156391A3 (en) 1992-02-19
JPH07119174B2 (ja) 1995-12-20
DE4016963A1 (de) 1991-11-28
UA26973A1 (uk) 2000-02-28
CA2043228C (en) 1998-07-14
HU911756D0 (en) 1991-12-30
IE76728B1 (en) 1997-11-05
ATE142884T1 (de) 1996-10-15
DE4016963C2 (uk) 1992-04-30
CN1057391A (zh) 1992-01-01
EP0458287A3 (en) 1992-04-08
LTIP580A (en) 1994-12-27
EG19730A (en) 1996-01-31
HU219223B (en) 2001-03-28
ES2091262T3 (es) 1996-11-01
DK0458287T3 (da) 1996-10-07
CA2043228A1 (en) 1991-11-26
IE911783A1 (en) 1991-12-04
LV10046B (en) 1995-02-20

Similar Documents

Publication Publication Date Title
ZA913692B (en) Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions
HU9202167D0 (en) Men's drawers
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
AU7397094A (en) Prevention and treatment of alzheimer's disease
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
GB8800276D0 (en) Medical treatment
AP9200355A0 (en) "Therapeutic agent"
EP0676197A3 (en) Gammalinolenic acid for the manufacture of a medicament for preventing artery reclosure.
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
NZ268039A (en) Use of efaroxan in treating parkinson's disease
HK44597A (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
AU114495S (en) Surgeon's hood
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IL88936A0 (en) Compositions for the prevention and treatment of periodontal disease
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids
CA70342S (en) Surgeon's hood
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
RU1833735C (ru) Cпocoб лeчehия ctepoидopeзиctehthыx фopm пузыpчatkи
HK1021685A1 (en) Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease
AU115958S (en) Fisherman's apron
PL290485A1 (en) Surgeon's learnig aid
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20000523

Year of fee payment: 10

PBON Lapse due to non-payment of renewal fee

Effective date: 20010524